- GE HealthCare Technologies' stock plummeted by 24.37% last week, marking a significant underperformance in the S&P 500 healthcare sector.
- Analysts predict an upside potential of 64.87% with an average price target of $99.75.
- The stock holds an "Outperform" rating from 20 brokerage firms, signaling potential growth opportunities.
GE HealthCare Technologies (GEHC, Financial) recently encountered a challenging period, witnessing a steep 24.37% drop in its stock price. This decline has positioned GEHC as the leading underperformer in the S&P 500 healthcare sector, amidst market volatility spurred by the latest tariff announcements. Investors are now evaluating whether this dip presents a buying opportunity or signals further potential declines.
Wall Street Analysts Forecast
According to price targets set by 18 analysts, GE HealthCare Technologies Inc (GEHC, Financial) is projected to reach an average target price of $99.75 within a year. Estimates range broadly, from a high of $115.00 to a low of $74.00. This average target indicates a possible upside of 64.87% from the current trading price of $60.50, suggesting substantial growth potential. For more detailed estimate data, visit the GE HealthCare Technologies Inc (GEHC) Forecast page.
The consensus recommendation from 20 brokerage firms places GE HealthCare Technologies Inc (GEHC, Financial) at an average brokerage recommendation of 2.1, reflecting an "Outperform" status. The rating scale ranges from 1, meaning Strong Buy, to 5, denoting Sell. This rating suggests that analysts are optimistic about GEHC’s performance in the near future, despite recent setbacks.
Investors would be wise to keep a close eye on GE HealthCare Technologies as it navigates these challenging market conditions. The current analyst ratings and price targets indicate potential for recovery and growth, making it a stock worth considering for those looking to capitalize on market corrections.
